Catalyst Wire Dossier Catalyst Wire Dossier

CS060380

CS060380 · Cascade Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CS060380, covering 2025-08-13 to 2025-08-13. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety, Tolerability and Pharmacokinetics of CS060380 in Healthy and Elevated LDL-C Subjects [Phase 1]

See pricing